[1]
2011. Alteration of Panel-Reactive Antibodies Following Treatment With Either Atorvastatin or Low-Dose Mycophenolate Mofetil in Sensitized Hemodialysis Patients. Iranian Journal of Kidney Diseases. 5, 5 (Aug. 2011), 342–346.